<DOC>
	<DOC>NCT01097382</DOC>
	<brief_summary>Primary Objective: To assess sleep satisfaction before and after Zolpidem CR (Ambien CR) administration Secondary Objective: To assess Psychomotor Performance before and after Zolpidem CR (Ambien CR) administration</brief_summary>
	<brief_title>Sleep Satisfaction and Psychomotor Performance of Adults</brief_title>
	<detailed_description />
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>Inclusion criteria: Patients consulting Psychiatrists (private or hospital) whatever the reason for consulting who present with chronic primary insomnia from the DSM IV (Diagnostic and Statistical Manual Revision 4). Accepting to participate in the study and signing informed consent Exclusion criteria: Pregnancy or breastfeeding. Current severe neuropsychiatric disorder (i.e. psychosis, obsessive compulsive disorder, major depression, dementia of Alzheimer or vascular type) according to DSM IV criteria. History of substance abuse or dependence (including alcohol) within the past year. Hypersensitivity to zolpidem or its excipients. Severe hepatic insufficiency Severe and/or acute respiratory insufficiency Myasthenia gravis. OTC (Over The Counter) sleep remedies or prescription sleep medications within 2 weeks or 5 halflife before screening. Severe medical illness. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>